CTRC enrolls first patients in novel phase II study for sarcoma -- living virus destroys cancer cell
... clinical study for patients with various types of sarcomas that have metastasized to the lung. CTRC is one of only three sites in the United States, and the only in Texas, enrolling patients. The novel anti-cancer therapy, REOLYSIN, is a living virus, not a chemotherapy drug, that is toxic to cancer cells ...Co-operation between GSF and clinic improves outlook for sarcoma patients
...e study of 341 high-risk patients with deep, local sarcomas shows a significant improvement in the response of...logical research - in the question whether certain sarcomas could be better treated with a combination of hyperthermia and other forms of therapy. In the cour...St. Jude shows gene test not needed if cancer drug given in low doses
...reat childhood solid tumors such as neuroblastoma, sarcomas and kidney tumors. A report on this study is in the June 20 issue of the Journal of Clinical Oncology. UGT1A1 makes an enzyme that modifies the activated form of irinotecan, a molecule called SN-38, so the body can easily remove it. Variations of...Oncolytics Biotech Inc. proceeds to initiate US Phase II sarcoma clinical trial
...dministration of REOLYSIN in patients with various sarcomas that have metastasized to the lung. The Principal...ose REOLYSIN in patients with bone and soft tissue sarcomas metastatic to the lung. REOLYSIN will be given intravenously to patients at a dose of 3x1010 TCID50......fic cancer and, second, you can design therapy for sarcomas in general because they share many common features...sed Genes Trigger Synovial Sarcoma Soft-tissue sarcomas are a group of cancers that develop in any part of the body in soft tissues like fat, nerve, muscle,...Reactivated gene shrinks tumors
...or 2 days of the p53 reactivation. In contrast, sarcomas (which affect connective tissues) did not undergo apoptosis but went into a state of senescence, or no growth. Those tumors took longer to shrink but the senescent tumor cells were eventually cleared away. The researchers are not sure why these two...ESMO International Symposium on Sarcoma and GIST
... for treatment. The latest research suggests that sarcomas may be particularly vulnerable to the kind of 'mag...tromal tumors (GIST). Now, other adult soft tissue sarcomas might follow in the near future." This possibility is of key interest for pharmaceutical companies s...New research identifies specific teenage and young adult cancers and points to possible causes
...eosarcoma, Ewing sarcoma, certain rare soft tissue sarcomas (such as alveolar soft part sarcoma), germ cell tu... 230 Hodgkin lymphomas, 46 osteosarcomas, 40 Ewing sarcomas and 230 germ cell tumours. These small numbers make it difficult for researchers to investigate the......issing?' "The existence of stem-like cells in bone sarcomas suggests that the study of stem cell biology may p... adolescent growth spurt. It makes sense that bone sarcomas occur in anatomic areas containing stimulated stem cells. A stimulated, abnormal stem cell might the...